19.6 C
New York
Saturday, June 3, 2023

Investors’ Patience Is Being Tested Right Now By Insmed Incorporated (NASDAQ: INSM)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Insmed Incorporated (INSM) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.07, or -0.36%, to $19.39. The Insmed Incorporated has recorded 23,238 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, “The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More”.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Insmed Incorporated is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $19.46 and fluctuated between $19.50 as its day high and $18.72 as its day low. The current market capitalization of Insmed Incorporated is $2.57B. A total of 0.82 million shares were traded on the day, compared to an average of 1.18M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, INSM has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 3,798 shares. Over the last 12 months, there were 18 BUYs and 24 SELLs from insiders. Insiders purchased 489,304 shares during that period but sold 375,308.

In the most recent transaction, Lewis William sold 7,099 shares of INSM for 18.12 per share on May 17. After the transaction, the Chair and CEO now owns 341,345 company shares. In a previous transaction on May 17, Adsett Roger sold 2,448 shares at 18.12 per share. INSM shares that Chief Operating Officer owns now total 160,333.

Among the insiders who sold shares, Schaeffer Orlov S Nicole disposed of 1,972 shares on May 17 at a per-share price of $18.16. This resulted in the Chief People Strategy Officer holding 93,525 shares of INSM after the transaction. In another insider transaction, Wise John Drayton sold 1,913 shares at $18.17 per share on May 17. Company shares held by the Chief Commercial Officer now total 106,047.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for INSM in the last 3 months, the mean price target is $39.15 with high estimates of $52.00 and low estimates of $28.00. In terms of 52-week highs and lows, INSM has a high of $28.94 and a low of $16.04.

As of this writing, INSM has an earnings estimate of -$1.12 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$1.02 per share and a lower estimate of -$1.24. The company reported an EPS of -$1.21 in the last quarter, which was -16.30% lower than expectations of -$1.04.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. INSM’s latest balance sheet shows that the firm has $716.78M in Cash & Short Term Investments as of fiscal 2021. There were $612.27M in debt and $135.17M in liabilities at the time. Its Book Value Per Share was -$0.33, while its Total Shareholder’s Equity was $410.47M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INSM is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles